ReviewNaunyn-Schmiedeberg's archives of pharmacology2026
A bibliometric assessment of research trends and emerging themes at the nexus of chemotherapy and depression.
Review in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIn recent years, research exploring the relationship between chemotherapy and depression has been on the rise. This study employs bibliometric methods to analyze the current state and emerging trends in this field, aiming to provide valuable insights for future investigations.
methodsRelevant literature on chemotherapy and depression published between January 1, 2014, and December 31, 2024, was retrieved from the Web of Science Core Collection. Following rigorous screening, bibliometric analyses-including publication volume assessment, collaboration network mapping, clustering analysis, and citation burst detection-were conducted using VOSviewer and CiteSpace software.
resultsThe number of publications on chemotherapy and depression has increased annually. The United States leads in both publication volume and citation frequency, and demonstrates the highest level of international collaboration. The institutions and authors with the most publications and citations are also based in the United States. Supportive Care in Cancer is the journal with the highest number of publications and citations in this field. The most cited article is "The Hospital Anxiety and Depression Scale" by A. S. Zigmond et al., published in Acta Psychiatrica Scandinavica in 1983. The twenty most frequently used keywords include quality of life, depression, breast cancer, chemotherapy, women, survivor, anxiety, prevalence, fatigue, symptom, therapy, impact, validation, management, health, hospital anxiety, intervention, pain, distress, and psychological distress. "Randomized controlled trial" is the keyword with the strongest citation burst in this field, while the keyword "support" is currently experiencing a surge in citations.
conclusionThis study employs bibliometric methods to analyze publication trends in the field of chemotherapy and depression, examining collaborative networks among countries, institutions, and authors, as well as recent research hotspots. The objective data presented herein provide valuable references for ongoing research in this domain.
Indexed as
Identifiers
40794179What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.